DLD Asset Management’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-38,436	Closed	-$3.74M	–	78
2023 Q1	$3.74M	Buy	38,436 +21,706	+130%	+$2.25M	0.38%	62
2022 Q4	$1.73M	Buy	16,730 +4,000	+31%	+$376K	0.18%	83
2022 Q3	$1.08M	Buy	12,730 +530	+4%	+$47.2K	0.1%	111
2022 Q2	$1.01M	Buy	+12,200	New	+$971K	0.08%	120
2021 Q2	–	Sell	-38,300	Closed	-$2.89M	–	154
2021 Q1	$2.89M	Buy	+38,300	New	+$3.13M	0.2%	81
2020 Q2	–	Sell	-23,720	Closed	-$2M	–	81
2020 Q1	$2M	Buy	23,720 +720	+3%	+$62K	0.24%	62
2019 Q4	$1.95M	Buy	23,000 +200	+0.9%	+$15.1K	0.22%	62
2019 Q3	$1.54M	Sell	22,800 -4,500	-16%	-$347K	0.12%	59
2019 Q2	$2.34M	Sell	27,300 -6,100	-18%	-$522K	0.15%	59
2019 Q1	$2.97M	Buy	33,400 +23,000	+221%	+$2.13M	0.19%	59
2018 Q4	$886K	Buy	+10,400	New	+$989K	0.08%	68